Bateman ED - Search Results

1

Roflumilast for asthma: Efficacy findings in placebo-controlled studies.

Meltzer EO, Chervinsky P, Busse W, Ohta K, Bardin P, Bredenbröker D, Bateman ED. Meltzer EO, et al. Among authors: bateman ed. Pulm Pharmacol Ther. 2015 Dec;35 Suppl:S20-7. doi: 10.1016/j.pupt.2015.10.006. Epub 2015 Oct 21. Pulm Pharmacol Ther. 2015. PMID: 26498386 Clinical Trial.

2

Roflumilast for asthma: Efficacy findings in non-placebo-controlled comparator and dosing studies.

Bateman ED, Bousquet J, Aubier M, Bredenbröker D, O'Byrne PM. Bateman ED, et al. Pulm Pharmacol Ther. 2015 Dec;35 Suppl:S11-9. doi: 10.1016/j.pupt.2015.10.002. Epub 2015 Oct 8. Pulm Pharmacol Ther. 2015. PMID: 26456372 Clinical Trial.

3

Roflumilast for asthma: Safety findings from a pooled analysis of ten clinical studies.

Chervinsky P, Meltzer EO, Busse W, Ohta K, Bardin P, Bredenbröker D, Bateman ED. Chervinsky P, et al. Among authors: bateman ed. Pulm Pharmacol Ther. 2015 Dec;35 Suppl:S28-34. doi: 10.1016/j.pupt.2015.11.003. Epub 2015 Nov 22. Pulm Pharmacol Ther. 2015. PMID: 26612545 Clinical Trial.

4

Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation history.

Bateman ED, Rabe KF, Calverley PM, Goehring UM, Brose M, Bredenbröker D, Fabbri LM. Bateman ED, et al. Eur Respir J. 2011 Sep;38(3):553-60. doi: 10.1183/09031936.00178710. Epub 2011 Jul 7. Eur Respir J. 2011. PMID: 21737553 Free article. Clinical Trial.

5

The correlation between asthma control and health status: the GOAL study.

Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. Bateman ED, et al. Eur Respir J. 2007 Jan;29(1):56-62. doi: 10.1183/09031936.00128505. Epub 2006 Oct 18. Eur Respir J. 2007. PMID: 17050557 Free article. Clinical Trial.

6

Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial.

Busse WW, Bateman ED, O'Byrne PM, Lötvall J, Woodcock A, Medley H, Forth R, Jacques L. Busse WW, et al. Among authors: bateman ed. Allergy. 2014 Nov;69(11):1522-30. doi: 10.1111/all.12480. Epub 2014 Aug 22. Allergy. 2014. PMID: 25040613 Free PMC article. Clinical Trial.

7

Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study.

Bateman ED, Bousquet J, Busse WW, Clark TJ, Gul N, Gibbs M, Pedersen S; GOAL Steering Committee and Investigators. Bateman ED, et al. Allergy. 2008 Jul;63(7):932-8. doi: 10.1111/j.1398-9995.2008.01724.x. Allergy. 2008. PMID: 18588561 Clinical Trial.

8

Roflumilast for asthma: Weighing the evidence.

Bateman ED, O'Byrne PM, Buhl R, Rabe KF. Bateman ED, et al. Pulm Pharmacol Ther. 2015 Dec;35 Suppl:S1-3. doi: 10.1016/j.pupt.2015.08.001. Epub 2015 Aug 13. Pulm Pharmacol Ther. 2015. PMID: 26278190 No abstract available.

9

Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.

Bateman ED, Linnhof AE, Homik L, Freudensprung U, Smau L, Engelstätter R. Bateman ED, et al. Pulm Pharmacol Ther. 2008;21(2):264-75. doi: 10.1016/j.pupt.2007.05.002. Epub 2007 May 21. Pulm Pharmacol Ther. 2008. PMID: 17604664 Clinical Trial.

10

Randomized comparison of ciclesonide 160 and 640 microg/day in severe asthma.

Bateman ED, Cheung D, Lapa e Silva J, Göhring UM, Schäfer M, Engelstätter R. Bateman ED, et al. Pulm Pharmacol Ther. 2008;21(3):489-98. doi: 10.1016/j.pupt.2007.11.002. Epub 2007 Nov 22. Pulm Pharmacol Ther. 2008. PMID: 18178494 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters